Mouse neoplasms induced by adenovirus type 12 contain common specific antigens detectable by the isograft rejection technique and are thereby similar to other viral tumors (1, 2, 3). Transplantation resistance against grafted tumor cells has been obtained either by pretreating mice with adeno 12 tumor cells or by infecting them with the adeno 12 virus (4, 3). Infection of the animals with adenovirus type 7 has also been found to produce immunity against transplanted adeno 12 tumors while infection with adenovirus type 5 has not (4). The adenovirus tumor system is in this respect different from other viral tumor systems in which the transplantation resistance induced by virus infection is limited to tumors induced by the infecting virus (2).
Mouse neoplasms induced by adenovirus type 12 contain common specific antigens detectable by the isograft rejection technique and are thereby similar to other viral tumors (1, 2, 3) . Transplantation resistance against grafted tumor cells has been obtained either by pretreating mice with adeno 12 tumor cells or by infecting them with the adeno 12 virus (4, 3) . Infection of the animals with adenovirus type 7 has also been found to produce immunity against transplanted adeno 12 tumors while infection with adenovirus type 5 has not (4) . The adenovirus tumor system is in this respect different from other viral tumor systems in which the transplantation resistance induced by virus infection is limited to tumors induced by the infecting virus (2) .
Specific, new antigens (neoantigens) of adeno 12 tumors have also been demonstrated with complement fixation (CF) and immunofluorescence techniques (6, 7) . These antigens have been reported as having an exclusively intracellular localization (7, 8) and are, therefore, probably distinct from the transplantation antigens which are considered to be represented on the cell surface (9, 10) . It appears to be of importance to clarify the possible relationships between the neoantigens and the transplantation antigen in adenovirus tumors. Furthermore the existence of a series of antigenically well characterized oncogenie and nononcogenie adenoviruses makes adeno tumors ideal for further research on the role of tumor-specific antigens in viral oncogenesis. As a first attempt in our approach to these problems we have applied an in vitro technique for the demonstration of the transplantation antigen of adeno tumor cells. The colony inhibition (CI) test was chosen, because it had been previously used * This work was supported by grants from the Swedish Cancer Society and The Swedish Medical Research Council; by Grant C-4747 from National Institutes of Health, United States Public Health Service, a General Research Support Grant from theNafional Insfitutesof Health to the University of Washington; and finally by an institutional research grant from the American Cancer Society, (IN-26H).
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successfully for the demonstration of the polyoma-specific transplantation antigens (11, 12) . This test is also capable of detecting cell-bound immunity reactions against tumor-specific antigens (13) . The present paper describes the demonstration of specific humoral and cell-bound immunity against the transplantation antigens of adenovirus 12-induced tumors. It also shows a crossreaction between the transplantation antigens of mouse and hamster adeno 12 tumors, similar to that previously reported in the polyoma system (12) . Finally, the in vivo finding of a cross-reaction in the immunity induced by adenovirus 7 and 12 is confirmed.
Materials and Methods
M/ce.--Mice of strains A/Sn, C3H/KL, A.SW/K.L, and A.CA/KL were used as well as A X CBA, A X C3H, A.BY X CBA, A.SW X C3H, and C3H X C57BL F1 hybrids. Their breeding and maintenance have been described (14) .
Aderan~us-Induced Tumors.--Five adeno 12 virus-induced sarcomas were used, most of which have been described previously (4) . Tumor A12.HA originated in a C3H female, tumors A12.HC and A12.HD originated in C3H males, and tumor A12.SBA in an A X CBA F1 female mouse. Tumor A12.Ha2 originated in a hamster inoculated with adenovirus type 12 when newborn. It was obtained from Dr. E. Norrby, The Swedish State Bacteriological Laboratory, Stockholm.
Tumors Having the Polyoma Tumor Antigen.--Three tumor lines with polyoma-specific transplantation antigens were used; namely one polyoma tumor clone SEWA-C10 of A.SW origin (15) and two clones, YAA-C1-C1-RC2 and YAA-C1-C3, of A/Sn origin. The latter two clones originated from a Moloney virus-induced leukemia, YAA, which had been repeatedly infected with polyoma virus and as a consequence had acquired the polyoma tumor transplantation antigen in addition to its original Moloney antigen (16) . The YAA-C1-C1-RC2 line had been cloned twice and the clones found to contain both the polyoma and the Moloneyspecific tumor antigens, t Repeated tests showed that none of the polyoma antigenic lines contained or released detectable polyoma virus (16 Other Tumors.--Sarcoma RSC was induced in an A/Sn mouse by Schmidt-Ruppin-Rous virus (RSV--SR) (17) , and sarcoma TCHF was derived from C3H embryo cells grown in serial tissue culture until "spontaneous transformation" occurred, after which they were serially passaged in vivo. ~ Virus.--Adenovirns types 12 (Huie), 7 (Gomen), and 5 were used for immunization in titers of 0.3-7.3 X 106 PFU (adeno 12), 1.3-21 X 106 PFU (adeno 7), and 45-75 X 106 PFU (adeno 5). The virus was given subcutaneously in five doses at weekly intervals.
Polyoma virus was originally obtained from Dr. B. E. Eddy and was used for immunization in an amount of 128 HA units/animal.
Sera.--Mice were treated with 2-24 doses of various tumor cells and/or viruses. Crude tumor cell suspensions were inoculated subcutaneously every 2nd wk into alternate flanks, and the animals were bled from the retroorbital plexus at various times (usually 1-2 wk) after the last dose of tumor. The detailed information for each serum is given in Table I .
Lymphocytes.--Axillary, cervical, inguinal, and mesenteric lymph nodes were harvested from mice sensitized with a mixture 1 : 1 of crude tumor cell suspensions and complete Freund's 1 Sjiigren, H. O., and I. HellstrSm. Unpublished data.
Minowada, J. Unpublished data. Significance of the difference in colony number after incubation with the serum in question compared to control serum (according to the Student t test). * The number of colonies formed after plating of 500 ceUs/Petri dish. Significance of the difference in colony number after incubation with the serum in question compared to control serum (according to the Student t test).
adjuvant. Information on the immunization procedure is given in a footnote to Table VII . Lymphocyte suspensions were prepared by pressing the nodes through a 60-mesh stainless steel screen into Eagle's culture medium.
The Colony Inhibition (C1) Technique.--The CI tests for detection of humoral antibody activity were performed as previously described (11, 12) . Trypglniwed cell suspensions were appropriately diluted in conditioned Eagle's medium containing 40% fetal calf serum. Volumes of 0.1 ml were added to tubes containing 0.1 ml antisera of different dilutions. The mixtures were incubated for 20 rain at 37°C, after which 0.8 ml of guinea pig complement, undiluted Table H. or diluted 1:2, was added. After another 60 rain of incubation the content of each tube was diluted with Eagle's medium containing 40% fetal calf serum and plated into 50-ram Falcon plastic Petri dishes in allquots of 4 ml. The dishes were incubated for 7 days at 37°C in a 5% COs in air atmosphere, stained with crystal violet, and the number of colonies counted. Usually three paralld dishes were used for each serum dilution. The mean number 4-the standard error of the mean is given in the tables. The significance of the differences in the number of colonies obtained with the various sera was evaluated by the Student t test. The CI method was modified also to detect cell-bound immunity (13) . Trypsinized tumor cell suspensions were added to Petri dishes and the cells allowed to attach to the surface of these during 12-24 hr, after which the culture medium was discarded and 0.3 ml of Wellcome phytohemagglutinin (PHA) diluted 1 : 15 was added, followed by 0.5 ml of a suspension of lymph node cells (from axillary, inguinal, cervical, and mesenteric lymph nodes) in culture medium. After 45 rain 4 ml Eagle's culture medium with 15~0 fetal calf serum was added to each Petri dish. The dishes were incubated for 3-4 days and afterwards stained and counted as in the plating experiments described previously. RESULTS .HD, and A12.SBA) were markedly fewer, after exposure of the tumor ceils to antisera from syngeneic donors immunized against any of these tumors, than those of controls for which hyperimmune sera against sarcoma TCHF (of no known viral origin) were used. Antisera directed against polyoma-, RSV-SR-, or Moloney-specific tumor antigens did not reduce colony numbers. Complement was needed in order to demonstrate colony inhibition with the specific antisera, All sera were obtained from mice treated with living mouse tumor cells, either untreated or irradiated with 8000 R immediately before inoculation.
Induction of Humoral (CI-) Antibodies against Adeno 12 Mouse Sarcomas by Immunization with Adeno 12 Mouse Tumors and with Adenovirus Types 12 and 7.
§ See ~ footnote to Table II. as in previous experiments (11, 12) . Reduction in colony numbers with specific antisera was most often in the range of 40-70 % and it was highly significant according to t tests (see tables). The data presented in Table IV show that the reduction was reproducible in repeated experiments with the same sera. In one experiment (serum 1625 in Experiment 7, Table IV ) no activity was demonstrated in undiluted or 1:2 diluted serum, although these dilutions were positive in other experiments. Since serum dilutions 1:4 and 1:8 in the same experiment gave colony inhibition, the negative findings with the more concentrated antiserum might be due to an anticomplementary effect. Also in other experiments with the same serum it was more effective in higher dilutions. As a rule, the activity of various sera was Sera from donors which had received four to five doses of adenovirus types 5, 7, or 12 were also tested against mouse adeno 12 tumors. As shown in Table V and Fig. 1 sera from adeno 12-and adeno 7-infected donors significantly reduced the plating efficiency of adeno 12 tumor cells, while sera from adeno 5- 3, and 4 ) and A12.HC (Experiment 2). Anti-H-2 lymph node cells were taken from A.CA mice immunized against A12.SBA tumor. Cells were isolated 2 wk after one single pretreatment in Experiments 1 and 2; 1 day and 2 wk after two doses in Experiments 3 and 4, respectively. infected donors were inactive, except in one case (Experiment 3 in Fig. 1 ). Several sera from virus-infected mice were tested and found to contain relatively high titers of antiviral HI and CF antibodies. No antiviral activity was found in the serum of donors immunized with adeno 12 mouse tumor cells.
Demonstration of Cross-Reactivity between Adeno 12 Tumors of Mouse and
Hamster by the CI Technique.--As shown in Table VI As shown in Table VII , lymphocytes sensitized against either the H-2 antigens or the specific tumor antigens of the A12.SBA cells significantly reduced colony numbers if added in a number of l0 T cells/dish; 10 6 cells gave a very weak reduction or no reduction at all, and 5 X 10 6 cells gave an intermediary reduction. Recent findings (unpublished) show that the addition of PHA is not a prerequisite for detecting inhibition with the sensitized lymphocytes.
DISCUSSION
The present findings demonstrate that adeno 12 mouse sarcomas share a specific antigen and that at least part of this antigen is present also in adeno 12-induced hamster tumor cells. Serum of adeno 7-infected mice was active against adeno 12 target cells, which may be explained by postulating a cross-reaction between (tumor) antigens induced by adenovirus types 12 and 7 in the infected mice.
The demonstrated specific antigenicity of adenovirus tumor cells is for several reasons considered to be identical with their previously reported specific transplantation antigenicity (4, 5) . First, the CI technique is analogous to "short time cytotoxic tests" (18) , which demonstrate cell surface antigens, the concentration of which determines the cellular sensitivity to humoral antibodies and complement (9, 10); a similar surface localization of the transplantation tumor antigen has been postulated to account for recognition of the antigenic tumor cells by sensitized lymphocytes in vivo (19) . Second, the demonstration that the CI technique also reveals cell killing after contact with immune lymphoid cells in the absence of complement brings the in vitro findings and the in vivo findings considerably closer together and suggests that the same surface antigens react under both conditions. Finally, the identity of the antigens detected by the CI test and the isograft immunity test is supported by the finding of colony inhibition with adeno 12 tumor cells exposed to serum from adeno 7-infected animals, since this parallels the isograft immunity demonstration in the same animals to adeno 12 tumor cells. On the other hand, complement-fixing (CF) antigens of adeno 7 and adeno 12 tumors do not cross-react. This indicates that the CI and CF antigens are different.
The cross-reactivity between adeno 12 tumors of mouse and hamster origin is analogous to the previously reported cross-reaction between polyoma tumors of mice and polyoma transformed BHK hamster cells (12) . Recently, evidence was obtained also of common antigens in RSV-SR sarcomas of mouse, hamster, and chicken2 These data support the concept that the tumor-specific transplantation antigens are coded for by the viral genome, which consequently must be maintained in tumor cells, even if they do not release infectious virus or contain detectable virion antigens (6, 20) . Direct evidence for the presence of at least some parts of the adenovirus DNA in hamster tumor cells has been recently reported by Fujinaga and Green using a virus DNA-tumor cell RNA hybridization technique (21) . In these experiments there was no evidence of a homology between adeno 7 DNA and adeno 12 tumor RNA. However, this does not exclude the presence of a common viral gene in adenovirus types 7 and 12 coding for the common transplantation antigen as suggested by the present results.
The successful in vitro demonstration of both humoral and cell-bound immunity directed against the adeno 12-specific transplantation antigens appears to provide tools for a closer study of the immune status of the primary tumor hosts before and after a visible tumor has developed. It is hoped that this will help to clarify the important question of the immunological events associated with the outgrowth of a primary antigenic tumor.
SIYM~AR¥
A colony inhibition (CI) technique was used to demonstrate in vitro tumorspecific antigenicity common for neoplasms induced by the adenovirus type 12. Immunization of mice against syngeneic mouse adeno 12 tumor cells evoked immtmity demonstrable against other adeno 12 neoplasms of mice and of hamster as well. The immunity was detected as antibody activity in the sera of specifically immunized mice and as a similar activity of the lymph node cells of these animals. The finding in transplantation experiments that infection with adenovirus types 12 and 7 induces an isograft immunity against adeno 12 tumors was confirmed by CI tests on the sera of virus-infected mice. The probable identity of the antigen detected by the CI technique and the tumor-specific transplantation antigen is discussed.
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